Secondary Cancers

A new retrospective analysis has added to building evidence that suggests chimeric antigen receptor T-cell therapy does not directly cause secondary malignancies.

Patients who received chimeric antigen receptor T-cell therapy did not exhibit increased risk for second primary malignancies compared with those who received other standard treatments, according to a systematic review and meta-analysis.

Childhood cancer survivors had a significantly higher prevalence of smoking than the general population, contrary to previous research, according to a study published in BMC Cancer.